Gland Pharma Limited — Others, 04-02-2025: Copy of Newspaper Publication

Gland Pharma has announced a board meeting to approve the unaudited financial results for the quarter and nine months ended December 31, 2024. The results, accompanied by audit reports from Deloitte Haskins & Sells, are available on their website and through stock exchanges. The publication in English and Telugu newspapers signals the company's commitment to transparency and shareholder communication.

This update may bolster investor confidence, as timely reporting reflects operational efficiency. However, the focus will be on results that could indicate revenue trends and future growth potential, presenting both opportunities and potential risks based on performance.